http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009104348-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-45 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2007-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009104348-A |
| titleOfInvention | STENT (OPTIONS) AND CATHETER CYLINDER |
| abstract | 1. A stent characterized by a polysulfone coating comprising an active agent, rapamycin and a polymer swelling in methanol, with a content of from 0.1 to 50% of the total weight of said coating. ! 2. The stent according to claim 1, wherein said coating includes at least one of the following methanol swellable polymers: polyvinylpyrrolidone, glycerin, polyethylene glycol, polypropylene glycol, polyvinyl alcohol, polyhydroxyethyl methacrylate, polyacrylamide, polyvalerolactone, poly-ε decalactone, polylactonic acid, polyglycolic acid, polylactide, polyglycolide, copolymer of polylactide and polyglycolide, poly-ε-caprolactone, polyhydroxybutyric acid, polyhydroxybutyrate, polyhydroxyvalerate, polyhydroxybutyrate copolymer and valerate, poly (1,4-dioxane-2,3-dione),! poly (1,3-dioxan-2-one), poly-para-dioxanone, polyanhydride, polymaleic acid anhydride, fibrin, polycyanoacrylate, polycaprolactone dimethyl acrylate, poly-b-maleic acid, polycaprolactonbutyl acrylate, polyblock oligonodiolone oligdione polyethers, polyethylene glycol and poly (butylene terephthalate), polypivotolactone, polyglycolic acid polytrimethyl carbonate, polycaprolactone glycolide, poly (g-ethylglutamate), poly (DTE-iminocarbonate), polysopolymer (DTE and DT-carbonate), by whether (biphenol A-iminocarbonate), polyorthoester, polyglycolic acid polytrimethyl carbonate, polytrimethyl carbonate, polyiminocarbonate, poly (N-vinyl) pyrrolidone, polyvinyl alcohol, polyetheramide, glycosylated complex polyester, polyphospho-ether, polyphenoxypropane [polyphenoxypropane] polyhydroxypene |
| priorityDate | 2006-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.